191 related articles for article (PubMed ID: 35214652)
1. Comparing SARS-CoV-2 Antibody Responses after Various COVID-19 Vaccinations in Healthcare Workers.
Kim YK; Minn D; Chang SH; Suh JS
Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214652
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response.
Di Meo A; Miller JJ; Fabros A; Brinc D; Hall V; Pinzon N; Ierullo M; Ku T; Ferreira VH; Kumar D; Pasic MD; Kulasingam V
J Appl Lab Med; 2022 Jan; 7(1):57-65. PubMed ID: 34342347
[TBL] [Abstract][Full Text] [Related]
3. Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers.
Nakai M; Yokoyama D; Sato T; Sato R; Kojima C; Shimosawa T
Heliyon; 2023 Jun; 9(6):e16547. PubMed ID: 37235203
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea.
Kim YK; Minn D; Song DY; Lee CH; Ryoo NH; Jeon CH; Song KE; Suh JS; Chang SH
J Korean Med Sci; 2021 Nov; 36(43):e294. PubMed ID: 34751011
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
6. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
7. Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study.
Aldali J; Meo SA; Al-Khlaiwi T
Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851109
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.
Mueller T
Clin Chim Acta; 2021 Jul; 518():9-16. PubMed ID: 33741357
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune response after different SARS-CoV-2 vaccination regimens.
Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
[TBL] [Abstract][Full Text] [Related]
10. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Antibody Response Elicited by ChAdOx1 and BNT162b2 COVID-19 Vaccine.
Kang YM; Minn D; Lim J; Lee KD; Jo DH; Choe KW; Kim MJ; Kim JM; Kim KN
J Korean Med Sci; 2021 Nov; 36(46):e311. PubMed ID: 34845875
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.
Olariu TR; Ursoniu S; Marincu I; Lupu MA
Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946275
[No Abstract] [Full Text] [Related]
13. Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands.
Juncker HG; Mulleners SJ; Ruhé EJM; Coenen ERM; Bakker S; van Doesburg M; Harinck JE; Rood RD; Bouhuijs JH; Oomen M; de Groot PCJM; Pajkrt PD; Korosi A; van Goudoever PJB; van Gils MJ; van Keulen BJ
EClinicalMedicine; 2022 May; 47():101393. PubMed ID: 35465077
[TBL] [Abstract][Full Text] [Related]
14. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland.
Paczkowska A; Hoffmann K; Michalak M; Hans-Wytrychowska A; Bryl W; Kopciuch D; Zaprutko T; Ratajczak P; Nowakowska E; Kus K
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335066
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Anti-SARS-CoV-2 S1 Receptor-Binding Domain Antibody Immunoassays in Health Care Workers Before and After the BNT162b2 mRNA Vaccine.
Carta M; Marinello I; Cappelletti A; Rodolfi A; Cerrito E; Bernasconi C; Gottardo M; Dal Lago F; Rizzetto D; Barzon E; Giavarina D
Am J Clin Pathol; 2022 Feb; 157(2):212-218. PubMed ID: 34463321
[TBL] [Abstract][Full Text] [Related]
16. Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.
Montoya JG; Adams AE; Bonetti V; Deng S; Link NA; Pertsch S; Olson K; Li M; Dillon EC; Frosch DL
Microbiol Spectr; 2021 Dec; 9(3):e0116221. PubMed ID: 34756093
[TBL] [Abstract][Full Text] [Related]
17. Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty
Held J; Esse J; Tascilar K; Steininger P; Schober K; Irrgang P; Alsalameh R; Tenbusch M; Seggewies C; Bogdan C
Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696171
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
19. Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford-AstraZeneca vaccines in healthcare workers in Thailand.
Phumisantiphong U; Chunhakan S; Manomaipiboon A; Maneerit J; Dechanuwong P; Trakarnvanich T; Oajaum W; Chan-In W
Vaccine X; 2023 Apr; 13():100277. PubMed ID: 36845212
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of IVD Kits for the Assessment of SARS-CoV-2 Antibodies to Evaluate the Humoral Response to Vaccination.
Lukaszuk K; Kiewisz J; Rozanska K; Dabrowska M; Podolak A; Jakiel G; Woclawek-Potocka I; Lukaszuk A; Rabalski L
Vaccines (Basel); 2021 Jul; 9(8):. PubMed ID: 34451965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
